WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KURA

Based on 6 analysts offering 12 month price targets for Kura Oncology Inc

Min Forecast
$15.00+41.24%
Avg Forecast
$27.17+155.81%
Max Forecast
$40.00+276.65%

Should I buy or sell KURA stock?

Based on 6 analysts offering ratings for Kura Oncology Inc.

Strong Buy
Strong Buy
2 analysts 33.33%
Buy
4 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KURA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KURA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their KURA stock forecasts and price targets.

KURA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-15
lockedlocked$00.00+00.00%2026-04-14
lockedlocked$00.00+00.00%2026-03-24
lockedlocked$00.00+00.00%2026-03-13
lockedlocked$00.00+00.00%2026-03-06
Anonymous
Leerink Partners
BuyMaintains$20.00+88.32%2026-01-13
HC Wainwright & Co.
Top 6%
95
BuyReiterates$40.00+276.65%2026-01-13

1 of 1

Forecast return on equity

Is KURA forecast to generate an efficient return?

Company
-30.1%
Industry
91.97%
Market
176.74%
KURA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KURA forecast to generate an efficient return on assets?

Company
-4.98%
Industry
27.38%
KURA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KURA earnings per share forecast

What is KURA's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$3.61
Avg 2 year Forecast
-$2.67
Avg 3 year Forecast
-$2.07

KURA revenue forecast

What is KURA's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$92.1M+28.63%
Avg 2 year Forecast
$188.7M+163.38%
Avg 3 year Forecast
$254.5M+255.2%
KURA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KURA revenue growth forecast

How is KURA forecast to perform vs Biotechnology companies and vs the US market?

Company
53.78%
Industry
34.36%
Market
13.75%
KURA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KURA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KURA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KURA$10.62$27.17+155.81%Strong Buy
AVTX$18.16$47.20+159.91%Strong Buy
REPL$11.27$6.00-46.76%Buy
DBVT$15.60$53.00+239.74%Strong Buy
SANA$3.28$7.00+113.41%Buy
View Top Biotech Stocks

Kura Oncology Stock Forecast FAQ

Is Kura Oncology Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: KURA) stock is to Strong Buy KURA stock.

Out of 6 analysts, 2 (33.33%) are recommending KURA as a Strong Buy, 4 (66.67%) are recommending KURA as a Buy, 0 (0%) are recommending KURA as a Hold, 0 (0%) are recommending KURA as a Sell, and 0 (0%) are recommending KURA as a Strong Sell.

If you're new to stock investing, here's how to buy Kura Oncology stock.

What is KURA's earnings growth forecast for 2026-2028?

(NASDAQ: KURA) Kura Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.27%.

Kura Oncology's earnings in 2026 is -$294,570,000.On average, 17 Wall Street analysts forecast KURA's earnings for 2026 to be -$320,324,541, with the lowest KURA earnings forecast at -$326,245,791, and the highest KURA earnings forecast at -$310,399,567. On average, 17 Wall Street analysts forecast KURA's earnings for 2027 to be -$237,098,574, with the lowest KURA earnings forecast at -$302,756,094, and the highest KURA earnings forecast at -$167,783,550.

In 2028, KURA is forecast to generate -$183,407,838 in earnings, with the lowest earnings forecast at -$283,616,341 and the highest earnings forecast at -$33,556,710.

What is KURA's revenue growth forecast for 2026-2028?

(NASDAQ: KURA) Kura Oncology's forecast annual revenue growth rate of 53.78% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.36%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Kura Oncology's revenue in 2026 is $71,639,000.On average, 18 Wall Street analysts forecast KURA's revenue for 2026 to be $8,180,380,186, with the lowest KURA revenue forecast at $6,317,894,008, and the highest KURA revenue forecast at $9,649,773,476. On average, 17 Wall Street analysts forecast KURA's revenue for 2027 to be $16,749,947,188, with the lowest KURA revenue forecast at $10,178,868,691, and the highest KURA revenue forecast at $26,345,568,301.

In 2028, KURA is forecast to generate $22,589,524,918 in revenue, with the lowest revenue forecast at $13,544,304,868 and the highest revenue forecast at $39,692,794,079.

What is KURA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: KURA) forecast ROA is -4.98%, which is lower than the forecast US Biotechnology industry average of 27.38%.

What is KURA's Price Target?

According to 6 Wall Street analysts that have issued a 1 year KURA price target, the average KURA price target is $27.17, with the highest KURA stock price forecast at $40.00 and the lowest KURA stock price forecast at $15.00.

On average, Wall Street analysts predict that Kura Oncology's share price could reach $27.17 by Jun 15, 2027. The average Kura Oncology stock price prediction forecasts a potential upside of 155.81% from the current KURA share price of $10.62.

What is KURA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KURA) Kura Oncology's current Earnings Per Share (EPS) is -$3.35. On average, analysts forecast that KURA's EPS will be -$3.61 for 2026, with the lowest EPS forecast at -$3.68, and the highest EPS forecast at -$3.50. On average, analysts forecast that KURA's EPS will be -$2.67 for 2027, with the lowest EPS forecast at -$3.41, and the highest EPS forecast at -$1.89. In 2028, KURA's EPS is forecast to hit -$2.07 (min: -$3.19, max: -$0.38).

What is KURA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: KURA) forecast ROE is -30.1%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.